CRBU logo

Caribou Biosciences (CRBU) Revenue

Annual Revenue

$34.48 M
+$20.63 M+148.91%

December 31, 2023


Summary


Performance

CRBU Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCRBUprofitabilitymetrics:

Quarterly Revenue

$2.02 M
-$1.44 M-41.57%

September 30, 2024


Summary


Performance

CRBU Quarterly Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

Related metrics

TTM Revenue

$11.47 M
-$21.64 M-65.35%

September 30, 2024


Summary


Performance

CRBU TTM Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCRBUprofitabilitymetrics:

CRBU Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+148.9%-91.5%-66.8%
3 y3 years+178.9%-91.5%-66.8%
5 y5 years+495.7%-91.5%-66.8%

CRBU Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+259.2%-91.5%at low-66.8%+19.6%
5 y5-yearat high+495.7%-91.5%+105.7%-66.8%+574.6%
alltimeall timeat high+495.7%-91.5%+105.7%-66.8%+574.6%

Caribou Biosciences Revenue History

DateAnnualQuarterlyTTM
Sep 2024
-
$2.02 M(-41.6%)
$11.47 M(-65.3%)
Jun 2024
-
$3.46 M(+42.6%)
$33.11 M(-0.9%)
Mar 2024
-
$2.43 M(-31.7%)
$33.40 M(-3.1%)
Dec 2023
$34.48 M(+148.9%)
$3.56 M(-85.0%)
$34.48 M(-0.4%)
Sep 2023
-
$23.66 M(+530.1%)
$34.61 M(+142.9%)
Jun 2023
-
$3.75 M(+7.2%)
$14.25 M(-3.0%)
Mar 2023
-
$3.50 M(-5.1%)
$14.69 M(+6.1%)
Dec 2022
$13.85 M
$3.69 M(+11.8%)
$13.85 M(+8.9%)
Sep 2022
-
$3.30 M(-21.2%)
$12.72 M(-5.0%)
Jun 2022
-
$4.19 M(+57.4%)
$13.39 M(+25.4%)
DateAnnualQuarterlyTTM
Mar 2022
-
$2.66 M(+4.1%)
$10.68 M(+11.2%)
Dec 2021
$9.60 M(-22.4%)
$2.56 M(-35.7%)
$9.60 M(+19.6%)
Sep 2021
-
$3.98 M(+169.4%)
$8.02 M(+53.0%)
Jun 2021
-
$1.48 M(-6.9%)
$5.24 M(-57.2%)
Mar 2021
-
$1.59 M(+61.2%)
$12.25 M(-0.9%)
Dec 2020
$12.36 M(+113.6%)
$984.00 K(-17.9%)
$12.36 M(+8.6%)
Sep 2020
-
$1.20 M(-85.9%)
$11.38 M(+11.8%)
Jun 2020
-
$8.48 M(+398.4%)
$10.18 M(+498.4%)
Mar 2020
-
$1.70 M
$1.70 M
Dec 2019
$5.79 M
-
-

FAQ

  • What is Caribou Biosciences annual revenue?
  • What is the all time high annual revenue for Caribou Biosciences?
  • What is Caribou Biosciences annual revenue year-on-year change?
  • What is Caribou Biosciences quarterly revenue?
  • What is the all time high quarterly revenue for Caribou Biosciences?
  • What is Caribou Biosciences quarterly revenue year-on-year change?
  • What is Caribou Biosciences TTM revenue?
  • What is the all time high TTM revenue for Caribou Biosciences?
  • What is Caribou Biosciences TTM revenue year-on-year change?

What is Caribou Biosciences annual revenue?

The current annual revenue of CRBU is $34.48 M

What is the all time high annual revenue for Caribou Biosciences?

Caribou Biosciences all-time high annual revenue is $34.48 M

What is Caribou Biosciences annual revenue year-on-year change?

Over the past year, CRBU annual revenue has changed by +$20.63 M (+148.91%)

What is Caribou Biosciences quarterly revenue?

The current quarterly revenue of CRBU is $2.02 M

What is the all time high quarterly revenue for Caribou Biosciences?

Caribou Biosciences all-time high quarterly revenue is $23.66 M

What is Caribou Biosciences quarterly revenue year-on-year change?

Over the past year, CRBU quarterly revenue has changed by -$21.64 M (-91.45%)

What is Caribou Biosciences TTM revenue?

The current TTM revenue of CRBU is $11.47 M

What is the all time high TTM revenue for Caribou Biosciences?

Caribou Biosciences all-time high TTM revenue is $34.61 M

What is Caribou Biosciences TTM revenue year-on-year change?

Over the past year, CRBU TTM revenue has changed by -$23.14 M (-66.85%)